Okay, interesting.
Skipping ahead now to the additional information we've seen here on the transformation agenda and strategic investment, the $30 million toward programming in the past three years, I think it's great news. We've certainly heard a little more testimony in regard to the programming you've been able to deliver in CSC, which I think is fantastic.
When we look at the effects of drugs specifically, and delivering these programs, can you give us a little more detail on how you see the presence of drugs in the institution affecting the front-line delivery of these programs?